Results 11 to 20 of about 4,064 (194)

QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-tube assays for detecting latent tuberculosis infection in Thai healthcare workers. [PDF]

Rev Inst Med Trop Sao Paulo, 2023
Detecting latent tuberculosis infection (LTBI) is important, especially in high-risk populations including healthcare workers (HCWs). QuantiFERON-TB Gold Plus (QFT-Plus) is a new version of the interferon-gamma release assays (IGRAs) to replace the ...
Rudeeaneksin J, Srisungngam S, Klayut W, Bunchoo S, Bhakdeenuan P, Phetsuksiri B.   +5 more
europepmc   +5 more sources

Performance comparison of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in detecting Mycobacterium tuberculosis infection among HIV patients in China [PDF]

PeerJ
Introduction No direct comparative study assessing QuantiFERON-TB Gold In-Tube (QFT-GIT) and QuantiFERON-TB Gold Plus (QFT-Plus) for Mycobacterium tuberculosis infection among persons living with HIV (PLHIV) in China has been conducted.
Peng Lu, Haitao Yang, Fang Ge, Kai Wu, Yilin Lian, Xiaoyan Ding, Jingjing Pan, Hui Ding, Wei Lu, Qiao Liu, Limei Zhu   +10 more
doaj   +5 more sources

QuantiFERON-TB Gold PLUS versus QuantiFERON-TB Gold In-Tube test for diagnosing tuberculosis infection [PDF]

The Korean Journal of Internal Medicine, 2020
Background/Aims QuantiFERON-TB Gold PLUS (QFT-PLUS) was developed as a new version of the interferon-γ (IFN-γ) release assay that contains an extra antigen tube to elicit a CD8+ T-cell response in addition to a CD4+ T-cell response.
Soo Han Kim, Kyung-Wook Jo, Tae Sun Shim
doaj   +4 more sources

Frequency and Factors of Indeterminate QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold PLUS Test Results in Rheumatic Diseases [PDF]

Journal of Clinical Medicine, 2021
We compared the results and differences of indeterminate rates between the QuantiFERON-TB Gold In-Tube (QFT-GIT) and QuantiFERON-TB Gold PLUS (QFT-PLUS) tests in patients with rheumatic diseases and analyzed the associated factors. Data of patients with rheumatic diseases who had undergone the QFT-GIT or QFT-PLUS test were used, and information ...
Sung Soo Ahn, Hyung Woo Kim, Youn-Hee Park   +2 more
exaly   +6 more sources

Fourth-Generation QuantiFERON-TB Gold Plus: What Is the Evidence? [PDF]

Journal of Clinical Microbiology, 2020
QuantiFERON-TB Gold Plus (QFT-Plus) is the latest generation of interferon gamma release assays (IGRAs) to receive approval from the U.S. FDA, replacing its predecessor, QuantiFERON-TB Gold In-Tube (QFT-GIT). The novelty of QFT-Plus is that it elicits a response from CD8 T cells, in addition to CD4 T cells, thus collecting a broader response from T ...
Catherine A Hogan, Madhukar Pai, Niaz Banaei   +2 more
exaly   +5 more sources

Evaluating the diagnostic accuracy of QIAreach QuantiFERON-TB compared to QuantiFERON-TB Gold Plus for tuberculosis: a systematic review and meta-analysis [PDF]

Scientific Reports
Accurate tuberculosis (TB) diagnosis remains challenging, especially in resource-limited settings. This study aims to assess the diagnostic performance of the QIAreach QuantiFERON-TB (QFT) assay, with a specific focus on comparing its diagnostic ...
Shima Mahmoudi, Sadra Nourazar
doaj   +2 more sources

Evaluation of QuantiFERON TB gold plus among TB household contacts in high incidence settings [PDF]

BMC Infectious Diseases
Background Accurately identifying and categorizing individuals who are latently infected is critical for developing prevention strategies against tuberculosis (TB) disease.
Sophie Nalukwago, Bonnie Thiel, Keith Chervenak, AnnaRitah Namuganga, LaShaunda L. Malone, Mary Nsereko, W. Henry Boom, Harriet Mayanja-Kizza   +7 more
doaj   +2 more sources

Standard E TB-Feron ELISA and Standard F TB-Feron FIA positivity rates and agreement with QuantiFERON-TB Gold Plus among TB high-risk population in Bandung, Indonesia [PDF]

Journal of Clinical Microbiology
Tuberculosis (TB) remains a global public health problem. The determination of tuberculosis infection (TBI) using interferon-gamma release assay has now been used widely.
Dewi Kartika Turbawaty, Syifa Nur Maulida, Darin Rizka Anadhea, Mulyanusa Amarullah Ritonga, Basti Andriyoko, Rudi Wisaksana, Agnes Rengga Indrati, Nanny Natalia Mulyani Soetedjo, Laniyati Hamijoyo, Raspati Cundarani Koesoemadinata, Bachti Alisjahbana, Ida Parwati   +11 more
doaj   +2 more sources

Evaluation of concordance of new QuantiFERON-TB Gold Plus platforms for Mycobacterium tuberculosis infection diagnosis in a prospective cohort of household contacts [PDF]

Microbiology Spectrum
Interferon-gamma (IFN-γ) release assays play a pivotal role in tuberculosis infection (TBI) diagnosis, with QuantiFERON-TB Gold Plus—an enzyme-linked immunosorbent assay (ELISA)—among the most widely utilized.
Cinthya Ruiz-Tagle, Patricia García, Mariluz Hernández, María Elvira Balcells   +3 more
doaj   +2 more sources

Comparing QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold in-tube for diagnosis of latent tuberculosis infection among highly TB exposed gold miners in South Africa [version 3; peer review: 2 approved, 1 approved with reservations] [PDF]

Gates Open Research, 2022
Background: QuantiFERON-TB-Gold-in-tube (QFT-GIT) is an interferon-gamma release assay (IGRA) used to diagnose latent tuberculosis infection. Limited data exists on performance of QuantiFERON-TB Gold-Plus (QFT-Plus), a next generation of IGRA that ...
Alison D. Grant, Thobani Ntshiqa, Raoul Mansukhani, Violet Chihota, Kavindhran Velen, Salome Charalambous, Lindiwe Nhlangulela, Thomas R. Hawn, Pholo Maenetje, Gavin Churchyard, Katherine Fielding, Robert Wallis   +11 more
doaj   +3 more sources